SEC 13F Intelligence

Sharpepoint LLC / LLY

Sharpepoint LLC’s Eli Lilly & Co Position

Does Sharpepoint LLC own Eli Lilly & Co (LLY)? Yes — 7.9K shares worth $7M (+4.31% of its 13F portfolio) as of Q1 2026, up from 7.8K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
7.9K
% of Portfolio
+4.31%
Quarters Held
4
currently held

Position History LLY

Reported value by quarter
Q4 ’24: $7MQ4 ’24Q1 ’25: $6MQ1 ’25Q4 ’25: $8MQ4 ’25Q1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.9K$7M+4.31%
Q4 20257.8K$8M+5.01%
Q1 20257.2K$6M+5.59%
Q4 20249.4K$7M+6.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sharpepoint LLC’s full portfolio or all institutional holders of LLY.